Stephen L. Chan

keynote 937 negative study for adjuvant #HCC in line with prior results from IMbrave 050. Unfortunately, still lack of positive #HCC trials. Novel strategies needed since given uniqueness of HCC adjuvant population and underlying cirrhosis. #GI26 @ASCO

A webinar to comment the Lancet Commission paper about liver cancer takes place on Thursday. We will comment geographic differences to be solved in order to secure access to effective treatments, as well as research challenges to be tackled . link hubs.li/Q03GK-R30

Proud and honored to be part of @TheLancet Commission on #livercancer #HCC led by @StephenLChan1. @HUNIMED @HumanitasMilano 3 Out of 5 Liver Cancer Cases Are Preventable, Study Finds nytimes.com/2025/07/28/wel… via @NYTimes

Incredibly proud to be part of @TheLancet Commission on #HCC! @StephenLChan1 @HUNIMED @HumanitasMilano

The FDA has issued a second rejection for the approval of rivoceranib plus camrelizumab as a first-line treatment for unresectable HCC. Here is the updated tracker of upcoming PDUFA dates and latest FDA approvals in oncology! Access real-time market intelligence and latest oncology insights with @Larvol PULSE. Check out the past FDA approvals: bit.ly/4iO7h1P #LARVOL #CancerResearch #PDUFA #Oncology #CancerData #ClinicalTrials #OncologyInsight Engage with the top voices on X discussing the latest PDUFA updates: @ArndtVogel | @StephenVLiu | @CathyEngMD | @AaronGoodman33 | @neerajaiims | @PGrivasMDPhD | @DrMLChua | @YJanjigianMD | @agz_eriksson | @SuyogCancer

Congratulations to the new #ilca #presidentelect @StephenLChan1 👏👏👏

We are thrilled to announce Prof. Vlad Ratziu as the new Editor-in-Chief of @JHepatology, starting January 2025! Joining him: ➡️Deputy Editors: @docberza & Frank Tacke ➡️Co-Editors: Tom H. Karlsen, @LorenzaRimassa, & @HeinerWedemeyer ➡️Senior Editor: Philip Newsome @EASLnews

Stellar ⭐️ panel at @myESMO GI 2024 @LorenzaRimassa @StephenLChan1 @ma5RN discussing management of #HCC 💪

In the QS Ranking by Subject 2024 @worlduniranking, @CUHKMedicine is ranked 1st in #HongKong, 2nd in #Asia and 28th globally this year, while our Nursing School @cuhknursing is the top spot both in #HongKong and #Asia and holds the 8th position globally. Details (Medicine): topuniversities.com/university-sub… Details (Nursing): topuniversities.com/university-sub…

The strong #HongKong 🇭🇰 contingent in #ESMOAsia23 ! @TonyMok9 @mollylisc @AyaHelali

@LandonLChan @mollylisc @TonyMok9 Well done @LandonLChan !

Happy to share my *first* poster in international conference on the recurrence pattern of HCC following curative surgery and RFA in the era of effective antivirals! Thx for the support! @StephenLChan1 @mollylisc @TonyMok9

Great discussion at the session on early drug development in GI cancers #ESMOAsia23 @myESMO @StephenLChan1 @CUHKMedicine

Excellent talks on unresolved issues and future directions on BTC/HCC/GEC/GC in ESMO ASIA 2023! @StephenLChan1 @LizzySmyth1 Dr. Do-Youn Oh

My dearest friend @mollylisc suggested to me to start using X Happy to share this mini-review on the inaugural issue of ESMO gastrointestinal oncology on our views on neoadjuvant immunotherapy for HCC! @StephenLChan1 @MissJanetKung sciencedirect.com/science/articl…

@StephenLChan1 addressing the challenging topic of personalized treatment for patients with #HCC at #ESMO23 @DrAngelaLamarca @JDekervel @ArndtVogel @myESMO

Ready for the #ESMO23 hepatobiliary session? Immunotherapy and molecularly targeted agents for #HCC and #CCA @DrAngelaLamarca @JDekervel @ArndtVogel @StephenLChan1 @myESMO

Huge THANK YOU to all speakers @LorenzaRimassa @ArndtVogel @StephenLChan1 and my co-chair @JDekervel for your expertise in this session today. We hopefully leave #ESMO23 convinced that #biopsies are the way forward to bring #PrecisionMedicine to #HCC 😉🧬 @myESMO

@ArndtVogel presenting and discussing #immunotherapy for patients with advanced #HCC at #ESMO23 @DrAngelaLamarca @JDekervel @StephenLChan1 @myESMO

How to improve quality of life #QOL of patients with #pancreatic cancer: jaundice, pain and ascites management, nutrition, exercise, radiotherapy #ESMO23 @StephenLChan1 @RadkaObermanno1 @ldawsonmd @myESMO